COMMITTEE ON LEGISLATIVE RESEARCH
OVERSIGHT DIVISION
FISCAL NOTE
L.R. NO. 2429-01
BILL NO. SB 782
SUBJECT: Health Care; Health Care Professionals; Insurance - Medical
TYPE: Original
DATE: January 30, 1998
FISCAL SUMMARY
ESTIMATED NET EFFECT ON STATE FUNDS Net Effect on All State Funds
FUND AFFECTED
FY 1999
FY 2000
FY 2001 None
Total Estimated
$0
$0
$0
ESTIMATED NET EFFECT ON FEDERAL FUNDS | |||
FUND AFFECTED | FY 1999 | FY 2000 | FY 2001 |
None | |||
Total Estimated
Net Effect on All Federal Funds |
$0 | $0 | $0 |
ESTIMATED NET EFFECT ON LOCAL FUNDS | |||
FUND AFFECTED | FY 1999 | FY 2000 | FY 2001 |
Local Government | $0 | $0 | $0 |
Numbers within parentheses: ( ) indicate costs or losses
This fiscal note contains 3 pages.
FISCAL ANALYSIS
ASSUMPTION
Officials from the Office of Administration, the Department of Insurance, the Department of Transportation, the Department of Conservation, the Department of Public Safety - Missouri State Highway Patrol, the Missouri Consolidated Health Care Plan, the Department of Corrections, and the Department of Social Services assume this proposal would not fiscally impact their agencies.
FISCAL IMPACT - State Government | FY 1999 | FY 2000 | FY 2001 |
(10 Mo.) | |||
$0 | $0 | $0 | |
FISCAL IMPACT - Local Government | FY 1999 | FY 2000 | FY 2001 |
(10 Mo.) | |||
$0 | $0 | $0 | |
FISCAL IMPACT - Small Business | |||
No direct fiscal impact to small businesses would be expected as a result of this proposal.
DESCRIPTION
This proposal would amend one section contained in HB 335 (1997), relating to the definition of maintenance drugs covered under a health maintenance organization (HMO). Under current law, both the enrollee and the enrollee's physician must approve the substitution of a generic drug for a prescribed maintenance drug. The law excludes "narrow therapeutic index drugs" from the definition of maintenance drugs to allow generic substitution for these drugs without physician/enrollee approval. This proposal would remove language that indirectly allows generic
substitution for narrow therapeutic index drugs, with the result that physician/enrollee approval would be required prior to a generic substitution for these drugs.
This legislation is not federally mandated, would not duplicate any other program and would not require additional capital improvements or rental space.
SOURCES OF INFORMATION
Department of Insurance
Missouri Consolidated Health Care Plan
SOURCES OF INFORMATION (continued)
Department of Social Services
Department of Conservation
Office of Administration
Department of Transportation
Department of Public Safety
Missouri State Highway Patrol
Department of Corrections
Jeanne Jarrett, CPA
Director
January 30, 1998